Profil

Profil is a CRO that provides development services for insulin biosimilars. Profil focuses on research in the fields of diabetes and obesity. We conduct pharmacodynamics, pharmacokinetics, biosimilar, safety and tolerability studies, as well as bridging studies, among others. As part of the AP@home project, we have participated in the development of the artificial pancreas and have been involved in the development of all categories of anti-diabetic drugs.